Sherief Abd-Elsalam
50
21
21
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
0.0%
0 terminated/withdrawn out of 50 trials
100.0%
+13.5% vs industry average
72%
36 trials in Phase 3/4
50%
1 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (50)
Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
Role: lead
Lacosamide in Neonatal Status Epilepticus
Role: lead
Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer
Role: lead
Role of Bumetanide in Treatment of Autism
Role: lead
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis
Role: lead
Effect of Direct-acting Antiviral Drugs on Erectile Function
Role: lead
Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta
Role: lead
Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding
Role: lead
Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics
Role: lead
Potential Role of Gastric Lavage by Paraffin Oil in Acute Aluminum Phosphide Poisoning
Role: lead
Pantoprazole in Cisplatin Nephrotoxicity
Role: lead
Role of Coenzyme Q in ADHD in Children
Role: lead
Role of Point of Care Ultrasound in Endotracheal Tube Placement
Role: lead
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
Role: lead
Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With Cirrhosis
Role: lead
Citicoline as Neuroprotector in Preterm
Role: lead
Citicoline as Neuroprotector in Neonates Exposed to Hypoxia
Role: lead
Docosahexaenoic Acid on Breath Holding Spells in Children
Role: lead
Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM
Role: lead
Impact of P53 and SIRT1 in Type 2 Diabetes
Role: lead